NewsBenzingaPharming confirme ses prévisions de ventes pour l'exercice 2026 à 380,000 M$-390,000 M$ contre 383,333 M$ estimés Pharming confirme ses prévisions de ventes pour l'exercice 2026 à 380,000 M$-390,000 M$ contre 383,333 M$ estimés Benzinga 2026.10.27 08:06 (GMT+0) Open on Benzinga Other news ChargePoint Unveils Channel Partner Program To Help European Resellers Capture Growing Demand For EV Charging Infrastructure Why Is Whirlpool Stock Falling Tuesday? Needham Maintains Buy on Applied Optoelectronics, Lowers Price Target to $170 CenterPoint Energy Q3 Adj. EPS $0.53 Beats $0.49 Estimate, Sales $2.191B Beat $2.173B Estimate Microsoft Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call TransUnion Raises Share Buyback Authorization By $1B To $2B Total
ChargePoint Unveils Channel Partner Program To Help European Resellers Capture Growing Demand For EV Charging Infrastructure
Microsoft Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
